+43-123-13-985|info@ces.b2sg.org

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Jerry Workman to the position of Editor at Cancer Epigenetics (CE) journal series.

Dr. Workman is an Investigator at the Stowers Institute for Medical Research (Kansas City, MO, USA). Prior to his current position, Dr. Workman was a Fellow at Harvard University School of Medicine and at the Massachusetts General Hospital (MGH). He was also an Investigator at the Howard Hughes Medical Institute (HHMI) as well as a Scientific Board Counselor of the National Cancer Institute (NIH/NCI). Dr. Workman is widely recognized for his research on histone acetyltransferases (HATs), notably for his discovery of several large HAT-containing complexes, including the Tip60 and SAGA complexes. In collaboration with Shelley Berger and David Allis, Dr. Workman was also first to discover the HAT activity of the TAFII250 subunit of TFIID. Dr. Workman served as Editor of Molecular and Cellular Biology and is currently Editor of EMBO Reports and of eLife. Dr. Workman was inducted into the American Academy of Arts and Sciences in 2013.

We at the Cancer Epigenetics Society are very excited to working with Dr. Jerry Workman, one of the foremost cancer epigeneticists and histone acetylation experts. We congratulate and welcome Dr. Workman to the Cancer Epigenetics Editorial Board .

2017-05-19T11:28:43+00:00